Key Points
Financial Express.com reached out to Vivek Sehgal, Director General, Organisation of Pharmaceutical Producers of India (OPPI) and he talked about issues like immunisation in India, current surge in COVID-19 cases, and regulatory challenges for pharmaceutical companies among others..
In terms of invention and innovation, the pharmaceutical industry and OPPI member companies have been at the forefront of developing new and improved vaccines to tackle various diseases and disorders such as polio, TB, hepatitis B, pneumonia, cancer, HPV, measles, influenza, pneumococcal, rubella, BCG, Covid-19, and meningitis, among others...
The pharmaceutical industrys continued efforts in the research and development of vaccines have led to significant progress in the healthcare sector, benefiting millions of people in India and globally...
OPPI remains committed to promoting the highest standards of quality and innovation in the pharmaceutical sector in India while working to improve accessibility and address pricing issues. One of our key focuses is to work for Bharat and aim to support the governments efforts to ensure that every Indian has access to safe and effective healthcare..
The Bharat Ke Liye approach highlights the contributions of the pharma sector and OPPI member companies approach towards building a healthier India and the crucial role it plays in the countrys economic growth..
You might be interested in
Healthcare execs expect M&A activity to rise again in 2024 -survey
14, Nov, 23Merger and acquisition (M&A) activity in the global healthcare sector should continue to rise next year, led by healthcare companies rather than private equity, according to a survey of industry executives.